Posted by Robert Lorsch | Filed under Posts by Robert Lorsch
You can take charge of your health by occupying an MMR account with all your family’s’ medical records and other important documents over the Thanksgiving holiday. We sympathize with those who have opted to take to the streets and sleep in tents to make their point. While we are all feeling the pain of a difficult time, we believe supporting the economy by shopping and investing in small business is another way to “Occupy Wall Street.” One way you can do a small part is to join in a grassroots movement to set up a personal health record using MyMedicalRecords while the family is together over the Thanksgiving holiday.
Because Thanksgiving is about families coming together, it is a time to make sure that everyone’s important medical records and vital documents are maintained in one place in the event of an emergency or natural disaster. Thanksgiving is the perfect opportunity to invest in starting a MyMedicalRecords.com Personal Health Record. Your family, including your pets, will appreciate it.
Thanksgiving is my favorite holiday of the year. First, it’s always a four-day weekend, so I actually get time to slow down. And even if I wanted to keep working, the tryptophan in the turkey puts me out for the count by 7:00 P.M. on Thanksgiving Day. It is also my wedding anniversary to Kira, which makes the memories and the celebration that much more special.
MMR has also evolved through two Secretaries of Health and Human Services from both parties, over two administrations, consistently focusing on Health IT and the importance of having a personal health record. I congratulate President Obama for his efforts to make affordable health care available to millions of people that didn’t have it in the past. That means more customers for MyMedicalRecords.com. And for that, why wouldn’t I be thankful.
MMRGlobal is growing despite the worst recession in modern times, and, despite a dismal world economic climate. In the past few months alone, ng Connect and MMR announced that MyMedicalRecords.com will be the first Personal Health Record to be featured in the ng Connect booth at the upcoming January 2012 Consumer Electronics Show in Las Vegas. REACH Air is offering MMR accounts to travelers, UST Global has become the newest strategic partner to MMR, OTC: MMRF has been picked by numerous analysts and other services as a stock to watch, while the Company has been invited to Qatar to explore a venture in the UAE. The Company is also actively working with Alcatel-Lucent to connect to telemedicine services and a high growth revenue cycle management group to integrate our products and services throughout their network of healthcare providers.
I’d like to take this opportunity to wish our many friends, employees, shareholders, and our strategic partners around the world a happy healthy Thanksgiving holiday. At MMR, we think of them as an extended family, and for that I am thankful.
Robert H. “Bob” Lorsch, CEO, MMRGlobal
4401 Wilshire Blvd., 2nd Floor, Los Angeles, CA 90010, Tel. 310-476-7002
Follow me on Twitter at BobLorschTweets
Tags: anti-cd20, Bob Lorsch, Chartis, China, Drug Interactions, EHR, Electronic Health Record, Electronic Medical Record, Electronic Medical Records, EMR, Kira Reed, Kodak, MMR, MMRGlobal, MMRPatientView, Personal Health Record, Robert Lorsch
Posted by Robert Lorsch | Filed under Uncategorized
Sometimes as I go through my very busy 18 hour (average) days I forget what life is about. I become immersed in the happenings of business, MMR’s responsibilities to its customers and shareholders and, most important, what the outcome is of all the energy we expend.
When I was very young (we’re talking 11) I was fortunate enough to meet a man named “Mel” who told me to always remember “the more you put into the universe the more you get back.”
At 11, I am not sure I really got the message, but throughout my years I realize more than ever how accurate and influential that statement was to my life. In my 20s, I became President of an advertising and sales promotion agency. And we somehow began to specialize in cause-related marketing.
As many of you know, cause-related marketing, simply put, means giving a portion of the revenue from an ad or promotion campaign to charity. As a result, we became one of the largest sales promotion agencies in the United States. Ultimately, we were absorbed into the Saatchi & Saatchi empire and had caused substantially more than ten million dollars to go to charity from our clients. These organizations included Special Olympics, UNICEF, the Muscular Dystrophy Association and numerous others.
Shortly thereafter, with SmarTalk’s market cap at times in excess of one billion dollars, I retired into philanthropy. As a result, The RHL Foundation Trust contributed additional millions of dollars to organizations like DARE America, the California Science Center (where the Robert H. Lorsch Family Pavilion is the gateway to the museum), The Thalians Mental Health Organization, Wildlife WayStation (http://www.youtube.com/watch?v=46tDuo-Q1ds), Muscular Dystrophy and numerous other great organizations.
Earlier this week, I received an email from an MMRF shareholder and, more importantly, former Favrille Phase II trial participant who reminded me of why I am working these 18 hour days.
As a shareholder they find the recent press announcements pertaining to the Company’s biotech assets “interesting.” However, as a Favrille clinical trial participant, they asked that I continue to think about the real value of MMRGlobal’s biotech assets…..namely, to help save lives and find a cure.
This particular person was a participant in the Favrille Phase II trials. Apparently, they are now seven years disease free. What they do not know is that I am also a cancer survivor of eleven years.
After my first call from Dr. Levy it became clear that there could be significant value in the Favrille intellectual property and biotech assets beyond the Anti-CD20 Antibodies. As a CEO it became incumbent upon me to make sure I did what reasonably could be done with the assets for the benefit of shareholders who have invested more than 140 million dollars. However, as important is my understanding and awareness that these assets also have the ability to help find more effective treatments and even a cure for a very dreaded disease.
So as we push forward on this scientific journey in the world of biotech I want MMRF followers to know that we are actively pursuing opportunities for both patients and shareholders to be a part of finding the keys to one or more cures somewhere in the 140 million dollars of research done by Favrille. One of the key drivers that keeps me going is to make sure that the experience of the person who sent me the email goes toward helping save thousands of lives for generations to come.
All MMRGlobal products and services have the potential to save lives and reduce medical costs and based upon the information given to me and the conversations I have had regarding the Company’s Biotech Portfolio make me believe that MMRGlobal will also somehow someday be a factor in the fight to cure cancer. That is why I continue to work as hard as I do, hence the statement, “the more we put into the universe the more we all get back.”
Robert H. “Bob” Lorsch, CEO, MMRGlobal
4401 Wilshire Blvd., 2nd Floor Los Angeles, CA 90010, Phone 310-476-7002
www.mymedicalrecords.com. www.mmrvideos.com, www.mmrmdvideos.com
Follow me on Twitter at phremrguru
Posted by Robert Lorsch | Filed under Uncategorized
In addition to our Personal Health Record and Professional Health IT products and services, MMR continues to learn more about its pre-merger Favrille assets, the value they can bring to our shareholders and the secrets they might hold for the benefit of Cancer research.
As discussed in our recent March 2nd news release, MMR has been informed that it may have opportunities to enter into relationships that could lead to a re-interpretation of the previous Favrille cancer vaccine trials. Through May of 2008 pre-merger Favrille had spent more than 140 million dollars on the creation and development of intellectual property. This IP includes clinical trials data from patient samples, patents and other assets. We look forward to sharing more information about these opportunities with you in the near future.
Based on continued discussions with the company’s biotech consultants and others we now understand that the IP may unlock ways to create “custom-made” cancer vaccines and other opportunities in cancer research. We understand that these assets could be of value to biopharmaceutical companies, academic institutions, research organizations and others.
When the Robert H. Lorsch Family Pavilion was built at The California Science Center http://tinyurl.com/y8nyxht, I had hoped it would become a gateway for discovery by children who passed through its entrance. Maybe some of those kids will use these assets to make a difference in the fight against Cancer. When I was growing up in Chicago I was not a very good student yet my favorite childhood place was the Museum of Science and Industry. I never understood why. There must be truth in the line from the book Illusions, by Richard Bach. “We teach best, what we need to learn the most”.
Robert H. “Bob” Lorsch,CEO MMR Information Systems Inc
Statements in this blog that are not strictly historical in nature constitute “forward-looking statements.” Such statements include, but are not limited to, statements regarding the Company’s assets including but not limited to its primary Health IT businesses, data from Specifid/Favid vaccine and clinical trials or it’s ability to enter into a successful agreement to enter into a relationship for a re-interpretation of the previous Favrille cancer vaccine trials and/or receive the necessary regulatory approvals for such trials the outcomes of which may not be known for some time. These includes, but are not limited to, risks and uncertainties related to the development and approval of biotechnology product candidates and Health IT products and services as discussed in the Company’s filings with the Securities and Exchange Commission. MMR Information Systems, Inc. (MMRF), Inc. is providing this information as of the date of this blog and, except as required by law, does not undertake any obligation to update any forward-looking statements contained herein as a result of new information, future events or otherwise.